(1 - 40 from 89
)
Cancer drug developers angling for center stage at ASCO
www.fiercebiotech.com
[FierceBiotech] - Pfizer's best hope at drawing attention lies in updating the data on axitinib, its recently approved treatment for renal cell carcinoma. And Lilly clearly hopes to impress analysts with ramucirumab, which is in 6 late-stage cancer studies.
Annual General Meeting of Active Biotech AB
www.reuters.com
[Reuters] an orally administered small molecule with unique immunomodulatory properties for the treatment of multiple sclerosis, TASQ for prostate cancer as well as ANYARA for use in cancer targeted therapy, primarily of renal cell cancer.
Identifying patients who benefit most from immune suppressant
medicalxpress.com
[Medical Xpress] - Everolimus is currently used as an immunosuppressant to prevent patients rejecting transplanted organs and in the treatment of renal cell cancer. Research is also being conducted into the drug's use in other cancers, including breast cancer.
Pitt aims to prove therapy can offer new cancer hope
articles.mcall.com
[Allentown Morning Call] - But it's effective in only 10 percent of the patients with renal-cell (kidney) cancer and melanoma who qualify for the treatment. The drug causes healthy tissue and organ cells to begin consuming themselves in a process known as autophagy — Greek for
sorted by relevance / date